Who Paid My Doc
A Phase 1 Randomized Open Label Fixed Sequence Study to Estimate the Effect of Pf06826647 on the Pharmacokinetics of Oral Contraceptive Steroids and to Estimate the Effect of Oral Contraceptive Steroids on Pharmacokinetics of Pf06826647 in Healthy Female Participants
Research payments
$682,821
Through program year 2020, $682,821 in research payments was reported against A Phase 1 Randomized Open Label Fixed Sequence Study to Estimate the Effect of Pf06826647 on the Pharmacokinetics of Oral Contraceptive Steroids and to Estimate the Effect of Oral Contraceptive Steroids on Pharmacokinetics of Pf06826647 in Healthy Female Participants, across 10 payments, paid by Pfizer Inc..
- Paid by
- Pfizer Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $433,817 | 8 |
| 2019 | Research | $249,005 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.